Morgan Stanley’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.3M | Sell |
|
|||||
|
2025
Q2 | $27.4M | Buy |
|
|||||
|
2025
Q1 | $22.9M | Sell |
|
|||||
|
2024
Q4 | $56.8M | Sell |
|
|||||
|
2024
Q3 | $79.4M | Buy |
|
|||||
|
2024
Q2 | $30.9M | Sell |
|
|||||
|
2024
Q1 | $33.5M | Sell |
|
|||||
|
2023
Q4 | $67.5M | Buy |
|
|||||
|
2023
Q3 | $20.9M | Sell |
|
|||||
|
2023
Q2 | $21.2M | Buy |
|
|||||
|
2023
Q1 | $6.39M | Buy |
|
|||||
|
2022
Q4 | $8.06M | Buy |
|
|||||
|
2022
Q3 | $1.02M | Sell |
|
|||||
|
2022
Q2 | $3M | Buy |
|
|||||
|
2022
Q1 | $2.15M | Buy |
|
|||||
|
2021
Q4 | $1.38M | Buy |
|
|||||
|
2021
Q3 | $966K | Buy |
|
|||||
|
2021
Q2 | $449K | Buy |
|
|||||
|
2021
Q1 | $187K | Sell |
|
|||||
|
2020
Q4 | $360K | Buy |
|
|||||
|
2020
Q3 | $146K | Buy |
|
|||||
|
2020
Q2 | $3K | Buy |
|